electroCore, Inc.
For the period ended Dec 31, 2025. Filed Mar 19, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 19, 2026
ECOR$7.72+7.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
ELECTROCORE, INC. AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(in thousands)
| Year ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net loss | $(13,966) | $(11,886) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Stock based compensation | 1,930 | 1,870 |
| Depreciation and amortization | 501 | 760 |
| Amortization of right of use assets | 1,174 | 498 |
| Amortization of debt discount | 135 | — |
| Write-down of licensed devices | 150 | — |
| Inventory reserve charge | 41 | — |
| Increase in provision for credit losses | 523 | 51 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (142) | (710) |
| Inventories | 16 | 713 |
| Prepaid expenses and other assets | (294) | 102 |
| Accounts payable | 2,450 | 1,048 |
| Accrued expense and other current liabilities | 635 | 831 |
| Operating lease liabilities | (1,340) | (225) |
| Net cash used in operating activities | (8,187) | (6,948) |
| Cash flows from investing activities: | ||
| Purchase of property and equipment | (66) | — |
| Sale (purchase) of marketable securities | 3,943 | (8,519) |
| Net cash provided by (used in) investing activities | 3,877 | (8,519) |
| Cash flows from financing activities: | ||
| Sale of common stock and warrants | 217 | 8,300 |
| Issuance of long-term debt | 7,500 | — |
| Debt issuance costs | (95) | — |
| Equity issuance costs | (94) | (232) |
| Proceeds from exercise of options | 98 | — |
| Proceeds from exercise of warrants | 1 | 371 |
| Net cash provided by financing activities | 7,627 | 8,439 |
| Effect of changes in exchange rates on cash and cash equivalents | 18 | 147 |
| Net decrease in cash and cash equivalents | 3,335 | (6,881) |
| Cash and cash equivalents – beginning of year | 3,700 | 10,581 |
| Cash and cash equivalents – end of year | $7,035 | $3,700 |
| Supplemental cash flows disclosures: | ||
| Proceeds from sale of state net operating losses | $48 | $122 |
| Interest paid | 397 | 13 |
| Supplemental schedule of noncash activity: | ||
| Insurance premium financing | 452 | 359 |
| Accounts payable settled through common stock and warrants | 1,856 | 1,006 |
| Accounts payable settled through the exercise of warrants | 495 | 495 |
| Non-cash debt issuance costs | 213 | — |
| Shares issued in connection with Avenue loan | 720 | — |
| Accrued purchases of property and equipment | 203 | — |
| Right-of-use asset and operating lease liability | — | 3,316 |
See accompanying notes to consolidated financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.